Obstructive sleep apnea phenotypes eligible for pharmacological treatment

Area of Science:

• Sleep Medicine
• Pharmacology
• Internal Medicine

Background:

• Obstructive sleep apnea (OSA) is a prevalent and increasing global health concern.
• OSA significantly impacts physical health, mental well-being, and socioeconomic factors.
• Current treatments like CPAP are effective, but alternative and emerging therapies are gaining traction.

Purpose of the Study:

• To review current data on distinct obstructive sleep apnea (OSA) phenotypes.
• To summarize the potential of pharmacological interventions for specific OSA phenotypes.
• To explore how different OSA phenotypes may respond to emerging drug therapies.

Main Methods:

• Literature review of clinical trials and research on OSA phenotypes.
• Analysis of studies investigating pharmacological treatments for OSA.
• Synthesis of data on the heterogeneity of OSA and treatment responses.

Main Results:

• Obstructive sleep apnea (OSA) presents with diverse clinical phenotypes.
• These phenotypes exhibit variations in comorbidities, cardiovascular risk, and treatment responses.
• Emerging pharmacological agents show promise for targeting specific OSA-related dysfunctions.

Conclusions:

• Understanding OSA phenotypes is crucial for personalized treatment strategies.
• Pharmacological approaches offer a new avenue for managing OSA, particularly in specific patient subgroups.
• Further research is needed to optimize drug selection based on OSA phenotype.